Glenna Spears, CNM | |
112 Helen St, Sauk City, WI 53583-1101 | |
(608) 643-3351 | |
(608) 643-3621 |
Full Name | Glenna Spears |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 112 Helen St, Sauk City, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740388248 | NPI | - | NPPES |
41273100 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 89021 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Glenna Spears, CNM 112 Helen St, Sauk City, WI 53583-1101 Ph: (608) 643-3351 | Glenna Spears, CNM 112 Helen St, Sauk City, WI 53583-1101 Ph: (608) 643-3351 |
News Archive
Good timing is vital in many situations of daily life, but is rarely something we consider. In a new dissertation from UmeƄ University in Sweden, Olympia Karampela shows that our ability for timing is something that can be trained and it seems to be connected with our cognitive capacity.
SUNY Downstate scientist Ilham Muslimov, MD, PhD, along with senior author Henri Tiedge, PhD, professor of physiology and pharmacology and of neurology, published a study suggesting that cellular dysregulation associated with certain neurodegenerative disorders may result from molecular competition in neuronal RNA transport pathways.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.
The product has proven efficiency in lab tests, although clinical trials are yet to be performed. After discovering that silver nanoparticles are capable of blocking the entry of Human Immunodeficiency Virus (HIV) into the organism, a group of researchers from the University of Texas, in collaboration with Humberto Lara Villegas, specialist in nanoparticles and virology from the University of Monterrey, Mexico (UDEM), create a vaginal cream to control the transmition of the virus.
› Verified 4 days ago